FDA Inspection
Sinopep-Allsino Biopharmaceutical Co., Ltd.Sinopep-Allsino Biopharmaceutical Co., Ltd. – FDA Inspection, Apr 22, 2016
Record Details
This FDA Inspection record concerns Sinopep-Allsino Biopharmaceutical Co., Ltd., with an inspection on April 22, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 22, 2016
- Product Type
- Drugs
View Company Profile
ID · e883feac-fd64-47de-a9e2-17d6fcf8f08d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 969680
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Sinopep-Allsino Biopharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sinopep-Allsino Biopharmaceutical Co., Ltd.
- FDA Inspection 1254530 - 2024-09-20
- FDA Inspection 1080987 - 2019-01-18
- FDA Inspection 883828 - 2014-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.